by iitri | Apr 12, 2019 | News
David McCormick has been selected to present on the development of novel agents to treat sleep-disordered breathing (SDB; sleep apnea) at the invitation-only Science2Startup (S2S)™ symposium on April 23, 2019, in Cambridge. The presenting group of 12 was...
by iitri | Aug 21, 2018 | News
IITRI-Vaccine-Antiinfectives-Lunch-n-Learn Title: Regulatory Approval Pathways for Vaccines and Antivirals: Laying the Groundwork Location: MassBio, 300 Technology Square, 8th Floor, Cambridge MA, 02139 Date/Time: Tuesday, September 25, 2018 Registration: 11 am...
by iitri | Jan 8, 2018 | News
IITRI will be presenting a poster at the ASM Biothreats 2018 Meeting, February 12-14 in Baltimore, MD. For more details, please contact us. Title: Humoral and cellular immune dynamics following Zika virus secondary challenge in non-human primates. Authors: J. M....
by iitri | Sep 5, 2017 | News
Dave McCormick, IITRI’s Director, will be presenting at Eurotox 2017 in a symposium session: Toxicology and Cellular Mechanisms of Electromagnetic Fields (EMF) – Health Aspects of Exposure to EMF Emitted by Wireless Mobile Systems and Emerging Technologies. His...
by iitri | Aug 11, 2017 | News
IITRI now has expanded animal biosafety level 3 (ABSL-3) capacity to conduct pathogen challenge studies for vaccines or therapeutics in non-human primates (NHPs). Our ABSL-3 laboratories include head-only aerosol infection by inhalation exposure and plethysmography...
by iitri | Jul 25, 2017 | News
A mouse pregnancy model is now available from IITRI to evaluate the ability of vaccines or antivirals for protection against Zika virus (ZIKV) maternal-fetal viral transmission and resulting fetal defects such as microcephaly. Details of this mouse model and its use...
Recent Comments